Macrolux, a Shenzhen, China-based medical technology company, raised nearly CNY100M in Series A funding.
The round was led by Legend Capital.
The company intends to use the funds to accelerate growth, expand operations and its business reach.
Founded in October 2020 and led by Zhang Weiqiang, General Manager, Macrolux is a medical technology company focusing on solutions for endoscopic interventional diagnosis and treatment. With a vision of detecting diseases earlier and offering patients better treatments, the company provides endoscopic interventional diagnosis and treatment solutions covering departments including urology, respiration, and digestion by leveraging its engine for innovation-driven development.
FinSMEs
